Fullscript

Fullscript Competitive Intelligence & Landscape

fullscript.com ·

Overview

Fullscript Overview

Fullscript is a Canadian-based digital health platform founded in 2011 that specializes in supporting healthcare providers in delivering whole person care. The company offers a comprehensive platform that integrates industry-leading labs, clinically effective supplements, and advanced tools to promote adherence and improve health outcomes (Exa, fullscript.com/about). With a workforce of approximately 575 employees, Fullscript serves over 100,000 healthcare professionals and more than 6 million patients across the United States and Canada, generating around $450 million in annual revenue (Welcome to the Jungle).

Fullscript's core services include personalized treatment planning, supplement management, and diagnostic testing, all aimed at fostering preventative and holistic healthcare practices. The company's mission is to help people get better by making preventative medicine more accessible, easier to practice for providers, and more engaging for patients. It emphasizes the importance of whole person health, focusing on prevention through diet, exercise, stress management, and clinically effective supplements (fullscript.com/about).

As a leader in health technology, Fullscript has expanded significantly through funding rounds, including a recent venture round in 2025, and has acquired other companies like Emerson Ecologics to further its mission of transforming health delivery (Nutraceuticals World). Its strategic focus is on creating an integrated, patient-centered healthcare experience that supports sustainable, preventative, and personalized medicine.

Competitors

Fullscript Competitors

ScriptSure by DAW Systems, Inc. stands out with its award-winning e-prescribing platform, emphasizing accuracy, security, and compliance, including full HIPAA adherence. It offers features like controlled substance prescribing, medication updates, and detailed cost transparency, targeting healthcare providers seeking reliable prescription management (source).

Webware.io is a notable competitor in the eCommerce and healthcare technology space, with a focus on digital marketing and online ordering solutions for health practices, though specific feature comparisons to Fullscript are less detailed (source).

InpharmD and Welldium are also key players, with InpharmD specializing in pharmacy management solutions and Welldium offering telehealth and wellness services, positioning themselves as comprehensive health tech providers that indirectly compete with Fullscript's supplement distribution and healthcare integration services (source).

Vitaminscript by Holistic Health Partners differentiates itself by providing high-quality supplements at 12-40% lower prices than Fullscript, with a focus on practitioner-direct access and personalized holistic advice, appealing to cost-conscious practitioners and patients (source).

In terms of market positioning, Fullscript is recognized for its extensive supplement catalog and integration capabilities, serving over 125,000 healthcare providers, with estimated revenue of around $94.2M and significant funding of $267M, indicating a strong market share in the practitioner supplement space (source, tracxn.com). Each competitor varies in focus, from ScriptSure’s prescription accuracy to Vitaminscript’s cost advantages, but all aim to capture segments of the healthcare and supplement distribution markets.

Alternatives

Fullscript Alternatives

Product & Pricing

Fullscript Product and Pricing Intelligence

Fullscript offers a free account option for both practitioners and patients, with no initial cost to access core features (fullscript.com). The platform emphasizes that providers and patients can join and use the service at no charge, supporting a wide range of healthcare practices and networks (fullscript.com).

While the basic account is free, Fullscript generates revenue primarily through a 10% convenience fee on supplement orders, which is lower than many competitors charging between 20-25% (leslibitel.com). The platform also offers optional paid features and tools, such as automated refill reminders, inventory management, and personalized supplement plans, aimed at enhancing practice efficiency and patient engagement (fullscript.com).

Pricing for labs and diagnostic testing is handled differently; all lab testing on Fullscript is cash-pay only, with flexible billing options including custom fees, practitioner pay, and patient pay, but no insurance reimbursement is available for these services (support.fullscript.com). Recent updates indicate that there are no tiered paid plans for the core platform, and the focus remains on free usage with optional add-ons for advanced practice needs (saasworthy.com).

Hiring & Layoffs

Fullscript Hiring and Layoffs

As of March 2026, Fullscript continues to demonstrate strong growth and active hiring, reflecting its strategic focus on expanding its healthcare technology platform. The company has recently expanded its leadership team, including new roles within its C-suite, to support ongoing growth initiatives (Fullscript blog). This leadership expansion signals a focus on scaling operations and innovating within the integrative health space.

In terms of hiring trends, Fullscript is actively recruiting for technical roles such as senior backend engineers and data scientists, emphasizing speed and quality in deployment, which aligns with their rapid development culture (Remotive; Fullscript careers). The company’s hiring patterns suggest a strategic emphasis on technological innovation, product development, and scaling their platform to serve over 125,000 practitioners and millions of patients (BounceWatch).

Regarding layoffs, there is no recent publicly available information indicating layoffs at Fullscript, which suggests the company remains focused on growth and talent acquisition. Their recent funding round in May 2025, raising $273.1 million, further supports their aggressive expansion strategy and long-term company stability (Fullscript funding). Overall, Fullscript’s hiring patterns and leadership investments signal a company committed to technological innovation and market expansion within the healthcare software industry.

Leadership

Fullscript Management and Leadership Team

The Fullscript management and leadership team includes key executives such as Kyle Braatz, the Co-founder and CEO, who has been instrumental in guiding the company's growth since its founding in 2011 (Fullscript). Kyle Braatz has a strong background in healthcare technology and strategic leadership, and he has been a driving force behind the company's expansion into the whole-person health market.

Recent leadership changes include Kyle Braatz officially becoming the CEO in 2021, after previously serving as President and Chief Revenue Officer, with co-founder Fran Towey transitioning to the role of Executive Chair and continuing as a member of the Board of Directors (Fullscript Blog). In 2023, Fullscript announced the addition of accomplished leaders such as Ashley Koch, who was appointed as Chief Financial and Strategy Officer, bringing extensive healthcare industry experience to the executive team (Fullscript Blog).

Furthermore, in 2024, Fullscript welcomed new visionary leaders to reinforce its commitment to whole-person health, signaling ongoing strategic growth and leadership expansion. The company also appointed Aimee Miller to its Board of Directors, highlighting its focus on strengthening governance and strategic oversight (Yahoo Finance). Overall, Fullscript's leadership team is characterized by experienced executives dedicated to innovation and growth in healthcare technology.

Financials

Fullscript Financial Performance, Fundraising, M&A

Fullscript has demonstrated significant financial growth and activity in recent years. The company is estimated to generate around $94.2 million in annual revenue, supported by a total funding of approximately $267 million across multiple rounds, with its latest funding round occurring in 2025 (CompWorth, Tracxn). Its valuation is not publicly disclosed, but industry estimates suggest an enterprise value ranging from $960 million to $1.4 billion (Dealroom).

In terms of fundraising, Fullscript has secured substantial capital, with a total of $267 million raised, indicating strong investor confidence and financial health. The company's growth is further evidenced by its recognition as one of Canada's Enterprise-Industry Leaders in 2025, reflecting rapid revenue growth and market impact (Fullscript Blog).

Regarding mergers and acquisitions, Fullscript recently completed the acquisition of Rupa Health, a San Francisco-based startup that facilitates laboratory testing management for practitioners. This acquisition aligns with its strategy to expand its service offerings and market reach, and it is on track to reach over $1 billion in annual revenues by 2025, according to its CEO (Ottawa Business Journal, Fullscript). Overall, Fullscript exhibits robust financial health, substantial funding, and active M&A activity, positioning it as a major player in healthcare technology.

Partnerships

Fullscript Partnerships, Clients and Vendors

Fullscript has established numerous notable partnerships, clients, and vendor relationships that significantly enhance its position in the healthcare industry. One of its key collaborations is with Oura, the maker of the popular Oura Ring, which allows biometric data from wearable devices to be integrated into clinical workflows, providing healthcare providers with real-time, personalized health insights (Fullscript). This partnership aims to improve whole-person care by combining wearable biometric data with lab results and treatment history, benefiting over 125,000 healthcare providers (BriefGlance).

In addition to the Oura partnership, Fullscript has formed alliances with technology companies such as Biocanic, Cerbo, Charmhealth, DrChrono, Healthie, Jane, Kalix, and ODX, to facilitate seamless health platform integrations that improve clinical efficiency and patient care (Fullscript). These integrations support providers in managing supplements, labs, and patient data within their existing healthcare systems. Furthermore, Fullscript's acquisition of Emerson Ecologics in 2022 has expanded its reach into integrative medicine, supporting over 70,000 healthcare professionals and more than 5 million patients, reinforcing its ecosystem of holistic health solutions (Fullscript).

Fullscript's ecosystem also includes partnerships with 3X4 Genetics, which enhances personalized care through genetic insights, enabling practitioners to tailor treatment plans based on genetic data (PR Newswire). Moreover, the platform collaborates with Elation Health to streamline supplement recommendations and improve patient adherence, further integrating its services into primary care practices (Elation Health). These strategic partnerships and integrations exemplify Fullscript’s commitment to advancing whole-person healthcare through collaborative technology and vendor relationships.

Events

Fullscript Event Participations

Based on the available search results, Fullscript actively participates in various industry events, conferences, webinars, and community initiatives to promote its platform and engage with healthcare professionals. Notably, Fullscript hosts and sponsors webinars focused on integrative medicine, whole person care, and treatment adherence, such as the webinars on metabolic health and the roots of anxiety, which are designed to educate and connect practitioners (Fullscript Webinars).

In addition, Fullscript has been involved in major industry gatherings like the Integrative Medicine and Health Symposium, where it showcases its platform's capabilities and its commitment to advancing integrative healthcare practices (Fullscript at the Integrative Medicine and Health Symposium). Furthermore, the company has organized or participated in large-scale summits, such as the Cardiometabolic Summit, which gathers industry leaders and clinicians to discuss proactive, whole person care (Financial Post).

While specific details about trade shows or community events are limited in the search results, it is clear that Fullscript maintains a strong presence in educational webinars, professional symposia, and industry summits, actively engaging with healthcare providers and industry leaders to promote its mission of improving patient care through integrative and functional medicine approaches.

Frequently Asked Questions

Who are Fullscript's top competitors in the healthcare technology space?

Fullscript's key competitors include ScriptSure, Vitaminscript, Webware.io, InpharmD, and Welldium. ScriptSure focuses on e-prescribing accuracy and compliance, while Vitaminscript offers lower-priced supplements. Webware.io provides eCommerce solutions for health practices, and InpharmD and Welldium offer pharmacy management and telehealth services, respectively.

How can I track Fullscript's strategic moves and market activity?

Staying informed about Fullscript's strategic initiatives involves monitoring various sources, including their press releases, blog, job postings, and participation in industry events like the Integrative Medicine and Health Symposium. You can also track their partnerships and acquisitions, such as their recent acquisition of Rupa Health. ForesightIQ automates this monitoring process, consolidating Fullscript's 'digital exhaust' into actionable insights.

What competitive intelligence sources are available for Fullscript?

Competitive intelligence on Fullscript can be gathered from sources like company websites, press releases, industry reports, social media, and job boards. Monitoring these sources provides insights into Fullscript's product development, hiring trends, and partnerships. A platform like ForesightIQ can automatically monitor these diverse sources to provide a comprehensive view of Fullscript's activities.

How does Fullscript compare to Vitaminscript in terms of supplement pricing?

Vitaminscript differentiates itself by offering high-quality supplements at prices 12-40% lower than Fullscript. This makes Vitaminscript an attractive option for practitioners and patients who are cost-conscious. Fullscript, however, competes with an extensive supplement catalog and a wide range of integration capabilities.

What is Fullscript's pricing strategy for practitioners and patients?

Fullscript offers a free account option for both practitioners and patients, with no initial cost to access core features. The platform generates revenue primarily through a 10% convenience fee on supplement orders, which is lower than many competitors. While the basic account is free, Fullscript also offers optional paid features and tools to enhance practice efficiency.

Is Fullscript currently hiring or laying off employees?

As of March 2026, Fullscript is actively hiring, particularly for technical roles like senior backend engineers and data scientists. Recent leadership expansions also indicate a focus on growth. There is no recent public information indicating layoffs at Fullscript, suggesting a continued focus on talent acquisition and expansion.

What market signals might indicate Fullscript's next strategic moves?

Key market signals to watch for include Fullscript's hiring patterns, product updates, partnership announcements, and participation in industry events. Increased hiring in specific areas like data science might suggest a focus on AI-driven features. New partnerships could signal expansion into new markets or service offerings.

What partnerships has Fullscript established to enhance its platform?

Fullscript has established partnerships with companies like Oura, Biocanic, Cerbo, Charmhealth, DrChrono, Healthie, Jane, Kalix, and ODX. The Oura partnership integrates biometric data from wearable devices into clinical workflows. These integrations aim to improve clinical efficiency and patient care by supporting providers in managing supplements, labs, and patient data within their existing healthcare systems.

How does Fullscript compare to ScriptSure as an alternative e-prescribing solution?

ScriptSure by DAW Systems, Inc. is a comprehensive e-prescribing solution that offers full integration with healthcare workflows, including controlled substance prescribing, medication updates, and detailed cost transparency. ScriptSure is suitable for practices prioritizing security, compliance, and streamlined workflows, with a focus on HIPAA compliance and user-friendly interfaces.

What are Fullscript's estimated annual revenue and funding?

Fullscript's estimated annual revenue is around $94.2 million. The company has secured substantial capital, with a total funding of approximately $267 million across multiple rounds, indicating strong investor confidence and financial health.

Who is the CEO of Fullscript and what is their background?

Kyle Braatz is the Co-founder and CEO of Fullscript. He has been instrumental in guiding the company's growth since its founding in 2011, and has a strong background in healthcare technology and strategic leadership, which he has used to facilitate Fullscript's expansion into the whole-person health market.

What was Fullscript's most recent acquisition, and what does it signify for their strategy?

Fullscript recently acquired Rupa Health, a San Francisco-based startup that facilitates laboratory testing management for practitioners. This acquisition aligns with Fullscript's strategy to expand its service offerings and market reach, supporting their goal of reaching over $1 billion in annual revenues. It signals a stronger focus on integrating lab testing into their platform.

Powered by ForesightIQ · Competitive intelligence from digital exhaust